Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Transdermal System in Osteoarthritis Pain
NCT00315458Phase 3Terminated
- Sponsor
- Purdue Pharma
- Start
- Dec 2003
- Primary completion
- Mar 2005
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of v1003 in osteoarthritis (OA), sponsored by Purdue Pharma. Started Dec 2003; status: terminated.
02
Drugs
v1003
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00315458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315458.